Accessed May 9, 2024 .] Approved for weight loss in November 2023 under the name Zepbound, tirzepatide was approved as the diabetes drug Mounjaro in 2022
Consider what youre already spending on weight loss attempts, gym memberships, diet programs, supplements, plus the hidden costs of weight-related health issues like diabetes medications, high blood pressure treatments, and their complications
Rotate injection sites systematically (abdomen, thighs, upper arms) to prevent irritation or lipohypertrophy [7]
The incidence of major adverse cardiovascular outcomes was 9% lower in the exenatide group than in the placebo group, but the difference was not statistically significant ( P = .06)
For more information contact us or schedule an appointment
Maintain a consistent schedule by taking your doses at evenly spaced intervals